The evolution of cells, over 6 months did not differ among the subpopulations apart from the stage III lung cancer patients, for whom the frequency of CD28+CD57- cells at baseline was significantly higher than the frequency after one month. The gene discussed is B3GAT1; the disease is lung carcinoma.